Slrx warrants
WebbLadenburg Thalmann & Co. Inc. is acting as the exclusive placement agent for the transaction. Salarius reduced the exercise price of Exercising Holders’ warrants from … WebbThe new Common Stock Purchase Warrants will be initially exercisable on the six month anniversary of the date of issuance, have a term of exercise of five (5) year thereafter, …
Slrx warrants
Did you know?
Webb11 dec. 2024 · The shares of common stock issuable upon exercise of the existing warrants are registered pursuant to a registration statement on Form S-1 ... SLRX. … Webb7 feb. 2024 · In addition, Salarius has granted the underwriter a 45-day option to purchase up to 1,252,173 additional shares of common stock and/or warrants to purchase up to …
Webb13 apr. 2024 · About SLRX. Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. WebbDid you get a call or text from 828-318-9114? View owner's full name, address, public records, and background check for 8283189114 with Whitepages reverse phone lookup.
WebbFind real-time SLRX - Salarius Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. WebbSalarius Pharmaceuticals shares outstanding from 2015 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares. Compare SLRX With Other Stocks From: To: Zoom:
WebbCheck out this Used 2016 Walker Bay Odyssey 310 SLRX for sale in Clearwater, FL 33760. View this Rigid Inflatable Boats (RIB) and other Power boats on boattrader.com. ... The Company offers the details of this vessel in good faith but cannot guarantee or warrant the accuracy of this information nor warrant the condition of the vessel. A buyer ...
Webb10 juni 2024 · Salarius Pharmaceuticals ( NASDAQ: SLRX) on Friday filed for resale of up to ~7M shares by selling stockholders, issuable on exercise of certain outstanding … designer art deco wallpaperWebbSalarius Pharmaceuticals, Inc. Common Stock (SLRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. designer archways for kitchensWebb6000 warrants FLKS. 240 of SLRX And 1100 in covered calls for FLKS. I was pretty bummed out when she dumped into single digits after the merger but I think we are … designer art business card caseWebb18 aug. 2024 · En warrant är ett hävstångsinstrument där du som innehavare har rätten att antingen köpa eller sälja underliggande tillgång till ett på förhand bestämt pris och en på … designer artificial flower arrangementsWebbSalarius Pharmaceuticals Proceeds from Issued Warrants (Quarterly) View 4,000+ Financial Data Types: Add Browse Proceeds from Issued Warrants (Quarterly) Chart … designer armchair malaysiaWebb25 mars 2024 · HOUSTON, March 10, 2024 (GLOBE NEWSWIRE) – Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options, today reported important corporate events and its financial results for the full year and the fourth … designer articulated fish pendant necklaceWebb11 dec. 2024 · These warrants were previously issued in Salarius’ public offering in February this year. The company reduced the exercise price of Exercising Holders’ … designer architectural builds